University of Maryland Establishes New Professorship to Propel Translational Biomedical Engineering Innovation

University of Maryland Launches New Professorship

The University of Maryland, Baltimore (UMB) is set to enhance its standing in the field of biomedical engineering through the establishment of the Edward and Jennifer St. John Endowed Professorship in Translational Biomedical Engineering and Innovation. This initiative is supported by a generous $1 million matching grant from the Maryland E-Nnovation Initiative Fund (MEIF), which will be combined with additional funding from UMB, bringing the total investment to $3 million.

The Push for Innovation

This new endowment is not merely a financial boost but a strategic move aimed at driving the development and commercialization of cutting-edge bioengineering technologies. Dean Mark T. Gladwin, MD, of UMSOM, emphasized the importance of this initiative in connecting teams of clinicians and engineers. The aim is to accelerate the progression of innovative medical technologies from conception to practical application, ultimately improving patient care and health outcomes.

This initiative aligns with last year’s launch of the Center for Translational and Experimental Medicine (CTEM) by UMB and the University of Maryland, College Park (UMCP). Funded through a remarkable $10 million donation from the St. Johns and the Edward St. John Foundation, along with additional grants, CTEM serves as a collaborative hub for addressing health challenges and advancing medical innovations.

A Focus on Collaborative Efforts

Dean Gladwin stated, "As Maryland continues to emerge as a national leader in biomedical technology, this matching grant will help us recruit a new scientific leader who can bring together teams of clinicians and engineers." The endowment will facilitate the development of new imaging tools, biomaterials, and AI-driven diagnostics, which are critical for formulating better treatment strategies for patients.

Additionally, UMB President Bruce E. Jarrell, MD, FACS, noted that the endowed professorship is vital for fulfilling CTEM's vision. He pointed out that contemporary health challenges require multidisciplinary approaches, reinforcing the need for collaboration among biomedical scientists and engineers.

The new position will focus on bridging the gaps between bioengineering and medicine, fostering research that translates into real-world solutions. By attracting a leader with a notable record in translational research and innovation, the endowment aims not only to elevate UMB’s reputation but also to establish it as a pivotal resource for integrating engineering insights into biomedical research.

Mentorship and Future Leaders

Osamah Saeedi, MD, Co-Director of CTEM, reiterated the excitement about the opportunity to recruit a faculty leader who can amplify biomedical innovation and train future generations of engineers and clinician-scientists. The endowment is a testament to UMB's commitment to sustaining impactful programs that intend to benefit both patients and researchers.

In addition to UMB, other local institutions like Bowie State University and Morgan State University have also engaged with the Maryland Department of Commerce to fund new research professorships. In total, the Maryland E-Nnovation Initiative (MEI) will earmark $5.8 million to establish these roles across various academic institutions.

The MEI was initiated by the Maryland General Assembly in 2014, aimed at promoting research in technical fields at colleges. The program has successfully disbursed over $100 million in funding, which has leveraged private contributions exceeding $111 million—as a means of ensuring that research in these vital areas can continue to thrive.

In conclusion, the establishment of this endowed professorship not only marks a significant advancement for UMB but also represents a broader commitment to fostering innovation in the bioengineering sector. By reinforcing collaborations between fields, UMB aims to be at the forefront of developing technologies that significantly enhance patient care and health outcomes.